Stay updated with breaking news from Bioengineer Working. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Israel's Sol-Gel (SLGL) has signed an exclusive licensing deal with Searchlight Pharma for the Canadian commercialization rights to its dermatology products Twyneo and Eposolay.
Pfizer has a pipeline with more than 90 drugs in development. Pfizer is developing two drugs capable of generating more than a billion sales. Competition is fierce but Pfizer is in the race.
EOM Pharmaceutical has filed to raise $25m in an IPO, primarily for product development and to repay an outstanding note. Click here for details on the EOM IPO.
Eye drug developer Belite Bio (BLTE) stock soared 160% following its $36M initial public offering. Shares of BLTE opened at $12.50 after pricing at $6 per American Depositary Share
VectorBuilder announced plans to build a $500 million gene delivery manufacturing and research campus in Guangzhou.